Farrell Stephen, McMaster Cyril, Gibson David, Shields Michael D, McCallion William A
Department of Child Health, Queen's University Belfast, Royal Victoria Hospital, Institute of Clinical Science, Belfast, BT12 6BJ Northern Ireland, UK.
J Pediatr Surg. 2006 Feb;41(2):289-93. doi: 10.1016/j.jpedsurg.2005.11.002.
Gastro-oesophageal reflux (GOR)-related aspiration is associated with respiratory disease, but the current "gold standard" investigation, the lipid-laden macrophage index (LLMI), is flawed. A specific marker of GOR-related aspiration should originate in the stomach, but not the lung. An assay to detect gastric pepsin in the bronchoalveolar lavage (BAL) of children was developed and validated.
Gastro-oesophageal reflux was diagnosed in 33 children using intra-oesophageal pH monitoring. Thirteen asymptomatic negative controls requiring endotracheal intubation for elective surgery and 5 positive control patients with observed aspiration were recruited. All subjects received a BAL; the fluid obtained was analysed for the pepsin content and the LLMI.
All subjects in the negative control group were negative for pepsin. The positive control group had a significantly greater median pepsin level (P < .01) compared with negative controls. Patients with proximal oesophageal GOR and chronic cough also had significantly elevated pepsin levels (P = .04). The LLMI was not significantly elevated by the presence of cough or GOR.
This study suggests that GOR-related aspiration plays a role in chronic cough in children with known GOR. Detecting pepsin in BAL fluid may therefore become an important adjunct in patient selection for antireflux surgery.
胃食管反流(GOR)相关的误吸与呼吸系统疾病有关,但目前的“金标准”检查——载脂巨噬细胞指数(LLMI)存在缺陷。GOR相关误吸的特异性标志物应起源于胃,而非肺。我们开发并验证了一种检测儿童支气管肺泡灌洗(BAL)液中胃蛋白酶的检测方法。
采用食管内pH监测对33名儿童诊断胃食管反流。招募了13名因择期手术需要气管插管的无症状阴性对照者和5名观察到有误吸的阳性对照患者。所有受试者均接受BAL;对获得的液体进行胃蛋白酶含量和LLMI分析。
阴性对照组所有受试者的胃蛋白酶均为阴性。与阴性对照组相比,阳性对照组的胃蛋白酶中位数水平显著更高(P <.01)。食管近端GOR和慢性咳嗽患者的胃蛋白酶水平也显著升高(P =.04)。咳嗽或GOR的存在并未使LLMI显著升高。
本研究表明,GOR相关的误吸在已知GOR的儿童慢性咳嗽中起作用。因此,检测BAL液中的胃蛋白酶可能成为抗反流手术患者选择的重要辅助手段。